$234 Million is the total value of Ghost Tree Capital, LLC's 35 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 61.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $18,995,000 | +4.3% | 500,000 | -31.0% | 8.11% | +58.6% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $18,126,000 | +35.4% | 235,000 | -21.7% | 7.74% | +106.0% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $15,877,000 | +61.8% | 130,000 | +36.8% | 6.78% | +146.2% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $15,513,000 | -17.4% | 300,000 | +9.1% | 6.62% | +25.6% |
| QQQ | New | INVESCO QQQ TRunit ser 1 | $13,314,000 | – | 50,000 | +100.0% | 5.68% | – |
| Sell | AMYLYX PHARMACEUTICALS INC | $12,933,000 | -16.5% | 350,000 | -36.4% | 5.52% | +27.1% | |
| CTIC | Sell | CTI BIOPHARMA CORP | $11,119,000 | -4.5% | 1,850,000 | -7.5% | 4.75% | +45.3% |
| SGEN | New | SEAGEN INC | $10,923,000 | – | 85,000 | +100.0% | 4.66% | – |
| ISEE | Sell | IVERIC BIO INC | $9,635,000 | +15.8% | 450,000 | -3.0% | 4.11% | +76.2% |
| COGT | Buy | COGENT BIOSCIENCES INC | $9,248,000 | +3.3% | 800,000 | +33.3% | 3.95% | +57.1% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $9,062,000 | -25.9% | 200,000 | +14.3% | 3.87% | +12.8% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $8,307,000 | – | 1,300,000 | +100.0% | 3.55% | – |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $7,860,000 | +16.5% | 40,000 | +33.3% | 3.36% | +77.2% |
| PCVX | Sell | VAXCYTE INC | $7,672,000 | -11.2% | 160,000 | -55.6% | 3.28% | +35.1% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $7,127,000 | -41.4% | 55,000 | -50.0% | 3.04% | -10.8% |
| Sell | ASTRIA THERAPEUTICS INC | $6,701,000 | +48.3% | 450,000 | -10.0% | 2.86% | +125.5% | |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $5,805,000 | +257.2% | 20,000 | -20.0% | 2.48% | +443.4% |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $5,538,000 | -47.4% | 300,000 | -23.1% | 2.36% | -20.0% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $4,820,000 | -56.1% | 165,000 | -69.2% | 2.06% | -33.2% |
| AKRO | New | AKERO THERAPEUTICS INC | $4,658,000 | – | 85,000 | +100.0% | 1.99% | – |
| PRVB | New | PROVENTION BIO INC | $4,228,000 | – | 400,000 | +100.0% | 1.80% | – |
| AVTE | Sell | AEROVATE THERAPEUTICS INC | $3,956,000 | +59.1% | 135,000 | -10.0% | 1.69% | +142.0% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $3,818,000 | -20.6% | 150,000 | -25.0% | 1.63% | +20.8% |
| VKTX | New | VIKING THERAPEUTICS INC | $2,820,000 | – | 300,000 | +100.0% | 1.20% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $2,583,000 | -61.0% | 225,000 | -57.1% | 1.10% | -40.6% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $2,475,000 | +14.3% | 125,000 | +38.9% | 1.06% | +73.8% |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $2,393,000 | -47.1% | 339,907 | -35.3% | 1.02% | -19.5% |
| RNA | New | AVIDITY BIOSCIENCES INC | $2,219,000 | – | 100,000 | +100.0% | 0.95% | – |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $1,173,000 | -42.9% | 80,000 | -33.3% | 0.50% | -13.2% |
| Sell | AADI BIOSCIENCE INC | $1,155,000 | -59.1% | 90,000 | -55.0% | 0.49% | -37.8% | |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $1,089,000 | – | 9,896 | +100.0% | 0.46% | – |
| XFOR | New | X4 PHARMACEUTICALS INC | $993,000 | – | 1,000,000 | +100.0% | 0.42% | – |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $876,000 | -79.5% | 20,000 | -69.2% | 0.37% | -68.9% |
| DSGN | Sell | DESIGN THERAPEUTICS INC | $850,000 | -49.2% | 82,853 | -17.1% | 0.36% | -22.6% |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $360,000 | -31.6% | 800,000 | -20.0% | 0.15% | +4.1% |
| BIIB | Exit | BIOGEN INC | $0 | – | -3,750 | -100.0% | -0.28% | – |
| ISEE | Exit | IVERIC BIO INCcall | $0 | – | -61,300 | -100.0% | -0.31% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -65,000 | -100.0% | -0.45% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -200,000 | -100.0% | -0.59% | – |
| Exit | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $0 | – | -300,000 | -100.0% | -0.65% | – | |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -60,000 | -100.0% | -0.78% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -75,000 | -100.0% | -1.30% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -1.41% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -1.46% | – |
| TCDA | Exit | TRICIDA INCcall | $0 | – | -500,000 | -100.0% | -1.47% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -435,000 | -100.0% | -1.56% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INCcall | $0 | – | -150,000 | -100.0% | -1.88% | – |
| SGEN | Exit | SEAGEN INCcall | $0 | – | -50,000 | -100.0% | -1.92% | – |
| Exit | AMYLYX PHARMACEUTICALS INCput | $0 | – | -500,000 | -100.0% | -3.95% | – | |
| Exit | DICE THERAPEUTICS INCcall | $0 | – | -700,000 | -100.0% | -3.98% | – | |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -425,000 | -100.0% | -4.42% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INCput | $0 | – | -500,000 | -100.0% | -5.20% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -500,000 | -100.0% | -11.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.